GSK1292263
GSK1292263 (S2149-GRP)
Products
Description
GSK1292263 is a novel GPR119 agonist, showing potential for the treatment of type 2 diabetes. Phase 2.
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | S2149 |
| Target | GPR |